Application Deadline: 31 May 2021
The COVID-19 global pandemic has been ongoing for over one year, resulting in loss and negative socio-economic impact on our Member Countries. Small businesses and Poor communities have been hit the hardest and require additional attention. With lessons from the pandemic, we can now imagine and create innovative pathways to recovery for a more resilient and prosperous future, by generating more jobs and better health outcomes. Innovation can change the way affected communities interact and interface with the world to ease the challenges and restrictions caused by the pandemic. Hence it’s crucial to crowdsource and support innovative ideas and inventions that address important needs.
The IsDB has a longstanding commitment to harnessing the power of Science, Technology, and Innovation (STI) to help solve the global development challenges. Our US $500 million Transform Fund, launched in 2018, invests in testing early-stage innovative ideas and in scaling innovation by providing seed money for innovators, entrepreneurs, startups, SMEs, and institutions. We provide needed initial funding or growth capital to develop and commercialize innovations that will generate economic and social impact.
THE CATEGORIES OF APPLICATION ARE:
Grants ranging from US$ 50,000-100,0002 – Scaling up of Innovative Programs in the Private Sector
Private Sector Equity Investment up to US$ 300,0003 – Commercialization of Technology in the Private Sector
Private Sector Equity Investment up to US$ 1,000,0004 – Capacity Building in Science, Technology, & Innovation
Grants ranging from US$ 100,000-150,000
SUCCESSFUL PROPOSALS WILL CONTRIBUTE TO ONE OF THE FOLLOWING:
- Creating innovative, high-value, locally produced products and services in IsDB Member Countries for local markets and export to international markets.
- Creating and delivering innovative low-cost solutions to serve poor communities in Member Countries to facilitate access to social and basic services interrupted by the pandemic. This includes but is not limited to 1) education and schools, 2) physical distancing and hygiene, 3) home delivery and shopping, 4) mental and psychological support, and 5) communication and virtual business.
- Boosting or enhancing manufacturing capabilities in Member Countries, particularly for strategically important products (e.g., vaccines, drugs, diagnostics, medical supplies, water and sanitation systems, energy systems, high value industrial products)
- Creating innovative products and services that that support supply chain management for strategically important products (e.g., vaccines, medical oxygen maintenance, medical supplies, etc.) in Member Countries.
- Applying advanced technologies (e.g. IoT, Big Data, Artificial Intelligence, Blockchain, Smart Sensors, etc.) to enable an autonomous Global Value Chain and create innovative and resilient supply chain, distribution and delivery systems for goods and services in Member Countries for heavily affected industries, with emphasis on building digital trust and addressing COVID-19 vaccines value chain challenges related to distribution and delivery.
- Capacity building interventions targeted at training youth and displaced workers in the digital skills needed to advance in new, innovative, and growing fields.
- Capacity building targeted at improving operational capacities of the institutions involved in COVID-19 vaccines research, production, distribution and delivery, regulation and standardization in OIC countries to reach the standard of quality assurance and safety required by the WHO for vaccine production and export(such activities may include training, experts’ visit, deployment of software applications, upgrading of laboratories facilities, awareness campaigns, etc.).
For More Information: